BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 23673338)

  • 1. Follicular lymphoma treatment decisions: put GELF on the shelf?
    Link BK
    Haematologica; 2024 Apr; ():. PubMed ID: 38654659
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular lymphoma.
    Yavaşoğlu İ
    Turk J Haematol; 2015 Mar; 32(1):94-5. PubMed ID: 25805689
    [No Abstract]   [Full Text] [Related]  

  • 3. Renal infiltration of follicular lymphoma.
    Petković I; Krstić M; Pejcić I; Vrbić S; Stojnev S; Cvetanović A; Balić M; Todorović M
    Turk J Haematol; 2014 Sep; 31(3):315-6. PubMed ID: 25330530
    [No Abstract]   [Full Text] [Related]  

  • 4. Considerations in the initial management of follicular lymphoma.
    Nastoupil L; Sinha R; Hirschey A; Flowers CR
    Community Oncol; 2012 Nov; 9(11):S53-S60. PubMed ID: 23544009
    [No Abstract]   [Full Text] [Related]  

  • 5. Follicular lymphoma: 2014 update on diagnosis and management.
    Freedman A
    Am J Hematol; 2014 Apr; 89(4):429-36. PubMed ID: 24687887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pathology of follicular lymphoma.
    Takata K; Miyata-Takata T; Sato Y; Yoshino T
    J Clin Exp Hematop; 2014; 54(1):3-9. PubMed ID: 24942941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional genomics lead to new therapies in follicular lymphoma.
    Oricchio E; Wendel HG
    Ann N Y Acad Sci; 2013 Jul; 1293():18-24. PubMed ID: 23676193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How we manage follicular lymphoma.
    Hiddemann W; Cheson BD
    Leukemia; 2014 Jul; 28(7):1388-95. PubMed ID: 24577532
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting follicular lymphoma: high versus low risk.
    Smith SM
    Hematology Am Soc Hematol Educ Program; 2013; 2013():561-7. PubMed ID: 24319232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transformed follicular non-Hodgkin lymphoma.
    Casulo C; Burack WR; Friedberg JW
    Blood; 2015 Jan; 125(1):40-7. PubMed ID: 25499449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted mutational profiling of peripheral T-cell lymphoma not otherwise specified highlights new mechanisms in a heterogeneous pathogenesis.
    Schatz JH; Horwitz SM; Teruya-Feldstein J; Lunning MA; Viale A; Huberman K; Socci ND; Lailler N; Heguy A; Dolgalev I; Migliacci JC; Pirun M; Palomba ML; Weinstock DM; Wendel HG
    Leukemia; 2015 Jan; 29(1):237-41. PubMed ID: 25257991
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of follicular lymphoma.
    Izutsu K
    J Clin Exp Hematop; 2014; 54(1):31-7. PubMed ID: 24942944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genome sequencing of lymphoid malignancies.
    Mullighan CG
    Blood; 2013 Dec; 122(24):3899-907. PubMed ID: 24041576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The optimal management of follicular lymphoma: an evolving field.
    Ujjani C; Cheson BD
    Drugs; 2013 Sep; 73(13):1395-403. PubMed ID: 23884816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL2 mutations are associated with increased risk of transformation and shortened survival in follicular lymphoma.
    Correia C; Schneider PA; Dai H; Dogan A; Maurer MJ; Church AK; Novak AJ; Feldman AL; Wu X; Ding H; Meng XW; Cerhan JR; Slager SL; Macon WR; Habermann TM; Karp JE; Gore SD; Kay NE; Jelinek DF; Witzig TE; Nowakowski GS; Kaufmann SH
    Blood; 2015 Jan; 125(4):658-67. PubMed ID: 25452615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progress against follicular lymphoma.
    Schatz JH; Oricchio E; Puvvada SD; Wendel HG
    Curr Opin Hematol; 2013 Jul; 20(4):320-6. PubMed ID: 23673338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The serine-threonine kinase p90RSK is a new target of enzastaurin in follicular lymphoma cells.
    Kheirallah S; Fruchon S; Ysebaert L; Blanc A; Capilla F; Marrot A; Alsaati T; Frenois FX; Benhadji KA; Fournié JJ; Laurent G; Bezombes C
    Br J Pharmacol; 2013 Dec; 170(7):1374-83. PubMed ID: 23992368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preclinical studies of Apogossypolone: a new nonpeptidic pan small-molecule inhibitor of Bcl-2, Bcl-XL and Mcl-1 proteins in Follicular Small Cleaved Cell Lymphoma model.
    Arnold AA; Aboukameel A; Chen J; Yang D; Wang S; Al-Katib A; Mohammad RM
    Mol Cancer; 2008 Feb; 7():20. PubMed ID: 18275607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Next Generation of Targeted Molecules for Non-Hodgkin Lymphomas: Small-Molecule Inhibitors of Intracellular Targets and Signaling Pathways.
    Choe H; Ruan J
    Oncology (Williston Park); 2016 Sep; 30(9):847-58. PubMed ID: 27633417
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.